SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-014835
Filing Date
2024-01-25
Accepted
2024-01-25 07:00:32
Documents
17
Period of Report
2024-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d154367d8k.htm   iXBRL 8-K 678859
2 EX-10.1 d154367dex101.htm EX-10.1 326466
3 EX-10.2 d154367dex102.htm EX-10.2 172674
4 EX-10.3 d154367dex103.htm EX-10.3 224805
5 EX-10.4 d154367dex104.htm EX-10.4 94189
6 EX-10.5 d154367dex105.htm EX-10.5 86255
  Complete submission text file 0001193125-24-014835.txt   2037734

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20240125.xsd EX-101.SCH 2856
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20240125_lab.xml EX-101.LAB 17235
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20240125_pre.xml EX-101.PRE 10816
11 EXTRACTED XBRL INSTANCE DOCUMENT d154367d8k_htm.xml XML 3327
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38130 | Film No.: 24558551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)